Shao‐Lee Lin

Randomized, Double-Blind, Placebo-controlled Study of Brodalumab, a Human Anti–IL-17 Receptor Monoclonal Antibody, in Moderate to Severe Asthma

William W. Busse, Stephen T. Holgate, Edward Kerwin et al. · American Journal of Respiratory and Critical Care Medicine · 2013 · 657 citations

Pharmacy, Immunology, Pharmacology +14

The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic

Guido Ferlazzo, Dolca Thomas, Shao‐Lee Lin et al. · The Journal of Immunology · 2004 · 566 citations · Full text

Life Sciences, Cell Biology, Immunology +15

Increase in TNF-α and inducible nitric oxide synthase-expressing dendritic cells in psoriasis and reduction with efalizumab (anti-CD11a)

Michelle A. Lowes, Francesca Chamian, Maria Veronica Abello et al. · Proceedings of the National Academy of Sciences · 2005 · 450 citations · Full text

Medicine, Dermatology, Immunology +17

A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of Brodalumab in Patients With Moderate-to-Severe Crohn’s Disease

Stephan R. Targan, Brian G. Feagan, Séverine Vermeire et al. · The American Journal of Gastroenterology · 2016 · 372 citations

Veterinary Medicine, Immunology, Pharmacotherapy +16

Oral GS-5806 Activity in a Respiratory Syncytial Virus Challenge Study

John P. DeVincenzo, Richard J. Whitley, Richard L. Mackman et al. · New England Journal of Medicine · 2014 · 337 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12